Pharmacokinetics of acyclovir in patients undergoing continuous venovenous hemodialysis

Therapeutic Drug Monitoring

Volumn 19, Issue 6, 1997, Pages 701-704

  Boulieu, Roselyne ^a,b   Bastien, Olivier ^c   Gaillard, Stéphanie ^a,b   Flamens, Claire ^c  

^a UNIVERSITÉ LYON 1   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Hopital Neuro Cardiologique   (France)

Author keywords

Acyclovir; CVVHD; Pharmacokinetics

Indexed keywords

ACICLOVIR;

ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; HEMODIALYSIS; HERPES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; PHARMACOKINETICS; PRIORITY JOURNAL; ULTRAFILTRATION; VEIN ANASTOMOSIS;

ACYCLOVIR; ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; RENAL DIALYSIS; ULTRAFILTRATION;

EID: 0031443241     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199712000-00016     Document Type: Article

References (12)

1. Elion GB, Furman PA, Fyfe JA, De Miranda P, Beauchamp L, Shieffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci 1977;74: 5716-20.
2. Whitley RJ, Gnann JW. Aciclovir: a decade later. New Engl J Med 1992;327:782-9.
3. Keating MR, Wilhelm MP, Walker RC. Strategies for prevention of infection after cardiac transplantation. Mayo Clin Proc 1992; 67:676-84.
4. Wagstaff AJ, Faulds D, Goa KL. Aciclovir a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:153-205.
5. De Miranda P, Good SS, Laskin OL, et al. Disposition of intravenous radioactive acyclovir. Clin Pharmacol Ther 1981;30:662-72.
6. Gill MJ, Burgess E. Neurotoxicity of acyclovir in end stage renal disease. J Antimicrob Chem 1990;25:300-1.
7. Golper TA. Drug removal during continuous hemofiltration or hemodialysis. In: Sieberth HG, Mann H, Stommvoll HK, eds. Continuous Hemofiltration. Basel, Switzerland: Karger, 1991;93:110-6.
8. Boulieu R, Galant C, Silberstein N. Determination of acyclovir in human plasma by high performance liquid chromatography. J Chromatogr 1997;693:233-6.
9. Morse GD, Shelton MJ, O'Donnell AM. Comparative pharmacokinetics of antiviral nucleoside analogues. Clin Pharmacokinet 1993;24:101-23.
10. Laskin OL, Longstreth JA, Whelton A, et al. Effect of renal failure on the pharmacokinetics of aciclovir. Am J Med 1982;73:197-201.
11. Jones T, Alderman C. Acyclovir clearance by CAVHD. Int Care Med 1991;17:125-6.
12. De Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983;12:29-37.